Dr Kelley D Smith, MD | |
2217 W Eldorado Pkwy, Mckinney, TX 75070-4358 | |
(972) 542-1444 | |
(972) 542-6967 |
Full Name | Dr Kelley D Smith |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2217 W Eldorado Pkwy, Mckinney, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396796637 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | M2114 (Texas) | Primary |
Entity Name | Dallas Physician Medical Services For Children Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194153650 PECOS PAC ID: 1759607906 Enrollment ID: O20150305000673 |
News Archive
Biodel Inc. today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 - two proprietary ultra-rapid-acting formulations of recombinant human insulin.
Amsterdam Molecular Therapeutics a world leader in gene therapy, today reported positive preclinical data from a study using an AAV gene therapy product to lower cholesterol.
Patients with stable coronary artery disease (CAD) had a lower need for urgent revascularisation when receiving fractional flow reserve (FFR)-guided PCI plus the best available medical therapy (MT) than when receiving MT alone. The results, from a final analysis of the FAME 2 trial, were presented today during a Hot Line session of ESC Congress 2012 in Munich.
Assessing glomerular filtration rate (GFR) using kidney filtration markers in blood is the standard means for determining kidney function, diagnosing kidney disease and measuring its progression. A higher filtration rate indicates healthy kidney function, while a lower rate points to various stages of kidney disease. A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the new CKD-EPI equation for calculating GFR is a better predictor of risk for kidney disease and death compared to the most widely used method. The findings suggest that switching to the CKD-EPI equation for calculating GFR could focus efforts more efficiently, and improve assessment of patient future risk and treatment of kidney disease. The study is published in the May 9 edition of JAMA.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kelley D Smith, MD 2217 W Eldorado Pkwy, Mckinney, TX 75070-4358 Ph: (972) 542-1444 | Dr Kelley D Smith, MD 2217 W Eldorado Pkwy, Mckinney, TX 75070-4358 Ph: (972) 542-1444 |
News Archive
Biodel Inc. today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 - two proprietary ultra-rapid-acting formulations of recombinant human insulin.
Amsterdam Molecular Therapeutics a world leader in gene therapy, today reported positive preclinical data from a study using an AAV gene therapy product to lower cholesterol.
Patients with stable coronary artery disease (CAD) had a lower need for urgent revascularisation when receiving fractional flow reserve (FFR)-guided PCI plus the best available medical therapy (MT) than when receiving MT alone. The results, from a final analysis of the FAME 2 trial, were presented today during a Hot Line session of ESC Congress 2012 in Munich.
Assessing glomerular filtration rate (GFR) using kidney filtration markers in blood is the standard means for determining kidney function, diagnosing kidney disease and measuring its progression. A higher filtration rate indicates healthy kidney function, while a lower rate points to various stages of kidney disease. A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the new CKD-EPI equation for calculating GFR is a better predictor of risk for kidney disease and death compared to the most widely used method. The findings suggest that switching to the CKD-EPI equation for calculating GFR could focus efforts more efficiently, and improve assessment of patient future risk and treatment of kidney disease. The study is published in the May 9 edition of JAMA.
› Verified 2 days ago
Lajuan Jones Chambers, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6587 Virginia Parkway, Mckinney, TX 75071 Phone: 972-548-8382 Fax: 972-547-9951 | |
Michelle L Roberts, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1872 N. Lake Forest Dr., Mckinney, TX 75071 Phone: 972-548-0758 Fax: 972-548-0425 | |
Dr. Nagaratina Chandrasekaran Salem, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6850 Tpc Dr, Suite 100, Mckinney, TX 75070 Phone: 214-383-4400 Fax: 214-383-4403 | |
Elizabeth Bonnet, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3701 Eldorado Pkwy Ste A, Mckinney, TX 75070 Phone: 972-548-7888 | |
Dr. Nicole Mae Sutton, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3701 Eldorado Pkwy Ste A, Mckinney, TX 75070 Phone: 972-548-7888 Fax: 972-562-1170 | |
Jeffrey Joel Alvis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 175 Ridge Rd, Suite 200, Mckinney, TX 75070 Phone: 214-544-2555 Fax: 214-544-2550 | |
Jennifer Lynne Valliere, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3701 Eldorado Pkwy Ste A, Mckinney, TX 75070 Phone: 972-562-7888 Fax: 972-562-0781 |